Related Experiment Video

Updated: Aug 12, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma

G J Cote1, N Wohllk, D Evans

  • 1UTMD Anderson Cancer Center, Houston, Texas 77030, USA.

Bailliere'S Clinical Endocrinology and Metabolism
|July 1, 1995
PubMed

Insights

Identifying RET proto-oncogene mutations revolutionized MEN2 management. Genetic testing now allows accurate risk assessment and personalized treatment strategies for hereditary and sporadic medullary thyroid carcinoma (MTC).

Area of Science:

  • Oncology
  • Genetics
  • Endocrinology

Background:

  • Multiple Endocrine Neoplasia type 2 (MEN2) is a genetic cancer syndrome.
  • Medullary Thyroid Carcinoma (MTC) is a primary malignancy associated with MEN2.
  • RET proto-oncogene mutations are causative in a significant percentage of hereditary and sporadic MTC cases.

Purpose of the Study:

  • To highlight the impact of identifying RET proto-oncogene mutations in MEN2 management.
  • To discuss the implications of genetic testing for MTC screening and clinical management.
  • To explore the potential future applications of mutational analysis in MTC.

Main Methods:

  • Identification and analysis of RET proto-oncogene mutations.
  • Development of genetic screening tests for individuals at risk of MTC.
  • Clinical management strategies based on genetic testing results.

Main Results:

  • RET proto-oncogene mutations explain over 95% of hereditary and 15-25% of sporadic MTC.
  • Genetic testing allows reassurance for 50% of at-risk individuals and targeted management for carriers.
  • Mutational analysis aids in excluding hereditary disease in sporadic MTC cases.

Conclusions:

  • RET mutation identification has transformed MEN2 management, enabling precise genetic screening and personalized care.
  • Genetic testing offers significant benefits for both unaffected and affected individuals within MEN2 families.
  • Further research into mutational analysis may lead to novel treatment and prevention strategies for MTC.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...